Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Covid-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients ; : 3-14, 2020.
Article in English | Scopus | ID: covidwho-2256529

ABSTRACT

An ongoing outbreak of pneumonia caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December 2009 in Wuhan, China, and was gradually spread around the world. This is the third coronavirus infection in two decades, after the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). It was officially named Corona Virus Disease 2019 (COVID-19) by the World Health Organization (WHO), in February 2020. Since then, the virus has become widespread, turning into a pandemic, in March 2020. Currently, the number of people diagnosed with COVID-19 worldwide has crossed the five million mark, causing more than 300,000 deaths. © Springer Nature Switzerland AG 2020.

2.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(2): 105-108, 2022 02.
Article in English | MEDLINE | ID: covidwho-1707579

ABSTRACT

Vocal cord paralysis is a rare but severe complication after orotracheal intubation. The most common cause is traumatic, due to compression of the recurrent laryngeal nerve between the orotracheal tube cuff and the thyroid cartilage. Other possible causes are direct damage to the vocal cords during intubation, dislocation of the arytenoid cartilages, or infections, especially viral infections. It is usually due to a recurrent laryngeal nerve neuropraxia, and the course is benign in most patients. We present the case of a man who developed late bilateral vocal cord paralysis after pneumonia complicated with respiratory distress due to SARS-CoV-2 that required orotracheal intubation for 11 days. He presented symptoms of dyspnea 20 days after discharge from hospital with subsequent development of stridor, requiring a tracheostomy. Due to the temporal evolution, a possible contribution of the SARS-CoV-2 infection to the picture is pointed out.


Subject(s)
COVID-19 , Vocal Cord Paralysis , COVID-19/complications , Humans , Intubation, Intratracheal/adverse effects , Male , SARS-CoV-2 , Tracheostomy/adverse effects , Vocal Cord Paralysis/etiology
4.
Revista espanola de anestesiologia y reanimacion ; 2022.
Article in English | EuropePMC | ID: covidwho-1678742

ABSTRACT

Vocal cord paralysis is a rare but severe complication after orotracheal intubation. The most common cause is traumatic, due to compression of the recurrent laryngeal nerve between the orotracheal tube cuff and the thyroid cartilage. Other possible causes are direct damage to the vocal cords during intubation, dislocation of the arytenoid cartilages, or infections, especially viral infections. It is usually due to a recurrent laryngeal nerve neuropraxia, and the course is benign in most patients. We present the case of a man who developed late bilateral vocal cord paralysis after pneumonia complicated with respiratory distress due to SARS-CoV-2 that required orotracheal intubation for 11 days. He presented symptoms of dyspnea 20 days after discharge from hospital with subsequent development of stridor, requiring a tracheostomy. Due to the temporal evolution, a possible contribution of the SARS-CoV- 2 infection to the picture is pointed out.

5.
"19th LACCEI International Multi-Conference for Engineering, Education Caribbean Conference for Engineering and Technology: """"Prospective and Trends in Technology and Skills for Sustainable Social Development"""" and """"Leveraging Emerging Technologies to Construct the Future"""", LACCEI 2021" ; 2021-July, 2021.
Article in Spanish | Scopus | ID: covidwho-1603166

ABSTRACT

A new reality has been presenting itself since 2020, given the suffering of the coronavirus;forcing humanity to oppose with preventive measures to reactivate those items negatively impacted by contagion, where the AEC sector (Architecture, Engineering and Construction) is involved, significantly affecting one of its most important stages, real estate presale, compromising to the project objective (scope, cost, time and quality) and to the client's objective (profitability and operability). However, it is time for an evolution to devise an optimal scenario, being a key period for the digital revolution and the application of technological tools to speed up the speed of sales, generating an immersive experience that makes it easier for the end customer to recognize the project more realistic and interactive to generate an accurate and conscious decision making. The article develops procedures for real estate and for the end customer willing to live a different experience to make the best decisions. In the last place, the validation of technical opinions of specialists was generated, highlighting the needs of the end customer to discern the parameters of realization of the designs and their interaction functionalities. © 2021 Latin American and Caribbean Consortium of Engineering Institutions. All rights reserved.

6.
Rev Esp Anestesiol Reanim (Engl Ed) ; 2020 Dec 26.
Article in English, Spanish | MEDLINE | ID: covidwho-1071884

ABSTRACT

Vocal cord paralysis is a rare but severe complication after orotracheal intubation. The most common cause is traumatic, due to compression of the recurrent laryngeal nerve between the orotracheal tube cuff and the thyroid cartilage. Other possible causes are direct damage to the vocal cords during intubation, dislocation of the arytenoid cartilages, or infections, especially viral infections. It is usually due to a recurrent laryngeal nerve neuropraxia, and the course is benign in most patients. We present the case of a man who developed late bilateral vocal cord paralysis after pneumonia complicated with respiratory distress due to SARS-CoV-2 that required orotracheal intubation for 11 days. He presented symptoms of dyspnea 20 days after discharge from hospital with subsequent development of stridor, requiring a tracheostomy. Due to the temporal evolution, a possible contribution of the SARS-CoV- 2 infection to the picture is pointed out.

7.
Revista Española de Anestesiología y Reanimación (English Edition) ; 2020.
Article in English | ScienceDirect | ID: covidwho-989130

ABSTRACT

Background and objectives There is limited information on outcome, complications and treatments of critically ill COVID-19 patients requiring admission to an intensive care unit (ICU). The aim of this study is to describe the clinical ICU course, treatments used, complications and outcomes, of critically ill COVID-19 patients admitted in seven ICU in Galicia region during the 2020 March–April pandemic peak. Methods Between March 21 and April 19, 2020, we evaluated critically ill COVID-19 patients admitted to the ICU of Anesthesia of seven hospitals in Galicia, northwestern Spain. Outcome, complications, and treatments were monitored until May 6, 2020, the final date of follow-up. Results A total of 97 critically ill COVID-19 patients were included. During ICU stay, mechanical ventilation became necessary in 80 (82.5%) patients, and tracheostomy in 22 (22.7%) patients. Prone position was used frequently in both intubated (67.5%) and awake (27.8%) patients. Medications consisted of antivirals agents (92.7%), corticosteroids (93.8%), tocilizumab (57.7%), and intermediate or high doses of anticoagulants (83.5%). The most frequent complications were ICU-acquired infection (52.6%), thrombosis events (16.5%), and reintubation (9.3%). After a median follow-up of 42 (34–45) days, 15 patients (15.5%) deceased, 73 patients (75.2%) had been discharged from ICU, and nine patients (9.3%) were still in the ICU. Conclusions A high proportion of our critically ill COVID-19 patients required mechanical ventilation, prone positioning, antiviral medication, corticosteroids, and anticoagulants. ICU complications were frequent, mainly infections and thrombotic events. We had a relatively low mortality of 15,5%. Resumen Antecedentes y objetivos Existe poca información sobre la evolución, complicaciones y los tratamientos recibidos por los pacientes críticos con COVID-19 que requieren ingreso en una unidad de cuidados intensivos (UCI). El objetivo de este estudio es describir la evolución clínica, los tratamientos utilizados, las complicaciones y resultados de pacientes críticos COVID-19 ingresados en siete UCI de Anestesiología en la Región de Galicia durante el pico de la pandemia en marzo-abril 2020. Métodos Entre el 21 de marzo y el 19 de abril de 2020 evaluamos todos los pacientes críticos COVID-19 ingresados en las UCI de Anestesiología de siete hospitales en Galicia, en el Noroeste de España. Los resultados, complicaciones y los tratamientos administrados se registraron hasta el 6 de Mayo de 2020, fecha final del seguimiento. Resultados Un total de 97 pacientes críticos COVID-19 fueron incluidos. Durante su estancia en UCI, 80 pacientes (82,5%) necesitaron ventilación mecánica, y 22 pacientes (22,7%) traqueotomía. El decúbito prono se usó frecuentemente en pacientes intubados (67,5%) y despiertos (27,8%). Las medicaciones usadas fueron antivirales (92,7%), corticoides (93,8%), tocilizumab (57,7%), y dosis intermedias y altas de anticoagulantes (83,5%). Las complicaciones más frecuentes fueron infecciones adquiridas en UCI (52,6%), eventos trombóticos (16,5%), y reintubationes (9,3%). Tras un seguimiento medio de 42 (34–45) días, 15 pacientes fallecieron (15,5%), 73 pacientes (75,2%) habían sido dados de alta de UCI y nueve pacientes (9,3%) permanecían todavía en la unidad. Conclusiones Un alto porcentaje de nuestros pacientes críticos COVID-19 requirieron ventilación mecánica, posición prona, medicaciones antivirales, corticoides y anticoagulantes. Las complicaciones en UCI fueron frecuentes, principalmente infecciones y eventos trombóticos. Tuvimos una mortalidad relativamente baja del 15,5%.

8.
Rev Esp Anestesiol Reanim (Engl Ed) ; 68(1): 10-20, 2021 Jan.
Article in English, Spanish | MEDLINE | ID: covidwho-882751

ABSTRACT

BACKGROUND AND OBJECTIVES: There are limited information on outcome, complications and treatments of critically ill COVID-19 patients requiring admission to an intensive care unit (ICU). The aim of this study is to describe the clinical ICU course, treatments used, complications and outcomes, of critically ill COVID-19 patients admitted in seven ICU in Galicia region during the 2020 March-April pandemic peak. METHODS: Between March 21 and April 19, 2020, we evaluated critically ill COVID-19 patients admitted to the ICU of Anesthesia of seven hospitals in Galicia, northwestern Spain. Outcome, complications, and treatments were monitored until May 6, 2020, the final date of follow-up. RESULTS: A total of 97 critically ill COVID-19 patients were included. During ICU stay, mechanical ventilation became necessary in 80 (82.5%) patients, and tracheostomy in 22 (22.7%) patients. Prone position was used frequently in both intubated (67.5%) and awake (27.8%) patients. Medications consisted of antivirals agents (92.7%), corticosteroids (93.8%), tocilizumab (57.7%), and intermediate or high doses of anticoagulants (83.5%). The most frequent complications were ICU-acquired infection (52.6%), thrombosis events (16.5%), and reintubation (9.3%). After a median follow-up of 42 (34-45) days, 15 patients (15.5%) deceased, 73 patients (75.2%) had been discharged from ICU, and nine patients (9.3%) were still in the ICU. CONCLUSIONS: A high proportion of our critically ill COVID-19 patients required mechanical ventilation, prone positioning, antiviral medication, corticosteroids, and anticoagulants. ICU complications were frequent, mainly infections and thrombotic events. We had a relatively low mortality of 15,5%.


Subject(s)
Anesthesia , COVID-19 , Aged , COVID-19/complications , COVID-19/therapy , Critical Care , Critical Illness , Female , Humans , Intensive Care Units , Male , Middle Aged , Prospective Studies , Spain
SELECTION OF CITATIONS
SEARCH DETAIL